DUBLIN, Dec. 16, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/k8hhr8/peptide) has announced the addition of the "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are actively investing in development of newer peptides for various applications and are also opting for newer technologies for syntheses of these peptides. Cancer is the leading cause of death globally; according to the WHO (World Health Organization), around 12.7 million new cancer cases occurred in the year 2008. About 7 million people die from cancer every year and it is estimated that there will be more than 16 million new cancer cases every year by 2020. With rise in cancer patients and metabolic diseases like diabetes, there has been a push in growth for peptide molecules since chemotherapy, which is the major mode of treatment for cancer, is facing major challenges due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body. Likewise, peptide application in various other treatments has opened a promising avenue for future growth of this market. New routes of peptide administration are being investigated; however the parenteral route continues to dominate this market and accounted for a share of almost 86% of the entire market. Similarly, the technology market is ruled by LPPS (long phase peptide syntheses) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses.This report analyzes the peptide therapeutics market by types of applications (cancer, metabolic, neurological diseases and others), route of administration, by types (innovative and generic), by API therapeutics market (in-house vs. CMO), by peptide therapeutics, and technology. Each of these markets is analyzed by studying the current and future market scenario, with estimation for the period 2010 - 2018 in terms of value in USD million. Key Topics Covered: 1 Introduction1.1 Report description1.2 Market segmentation1.3 Scope of the report1.4 Research methodology1.5 Assumptions2 Executive Summary3 Global Peptide Therapeutics Market Dynamics3.1 Overview3.2 Drivers3.3 Restraints & challenges3.4 Opportunities3.5 Porters five forces analysis3.6 Market attractiveness analysis3.7 Peptide therapeutics - emerging technologies & trends3.8 Regulatory policies4 Global Peptide Therapeutics Market Analysis, By Applications5 Global Peptide Therapeutics Market, by Route of Administration5.1 Introduction5.2 Parenteral Route5.3 Oral Route5.4 Pulmonary Route5.5 Mucosal Route5.6 Others (Intradermal & Nasal)6 Peptide Therapeutics Market - Generic & Innovative Segments6.1 Introduction6.2 Peptide Therapeutics - Innovative market6.3 Peptide Therapeutics - Generic market7 API Peptide Therapeutics Market, In-house Vs CMO7.1 Introduction7.2 API peptide therapeutics - In-house market7.3 Contract Manufacturing Organizations (CMO)8 Peptide Therapeutics Market, By Technology8.1 Introduction8.2 Solid Phase Peptide Synthesis (SPPS)8.3 Liquid Phase Peptide Synthesis (LPPS)8.4 Hybrid Technology9 Peptide Therapeutics Market, By Geography9.1 Introduction9.2 North America9.3 Europe9.4 Asia 9.5 Rest of World10 Market Share Analysis10.1 Market share by key players10.2 Market share by key players in peptide drugs market10.3 Market share by key players in CMO segment11 Recommendations11.1 Success strategies11.2 Barriers to be considered12 Company Profiles Companies Mentioned:
- Amgen, Inc.
- Amylin Pharmaceuticals LLC Bristol-Myers Squibb (BMS)
- AstraZeneca PLC
- Bachem Holding AG
- Eli Lilly and Company
- GlaxoSmithKline (GSK)
- Lonza Inc.
- Merck & Co.
- Novartis AG
- Novo-Nordisk A/S
- Pfizer, Inc.
- PolyPeptide Group.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/k8hhr8/peptide
Media Contact:Laura Wood , +353-1-481-1716, firstname.lastname@example.org SOURCE Research and Markets